Tonix Pharmaceuticals Holding Corp. reported earnings of -$ 2.89 per TNXP share on Nov 9, 2026, beating analysts' expectations by
| Report Date | Nov 9, 2026 |
|---|---|
| Forecasted EPS | -$ 2.39 |
| Earnings Per Share (Surprise) | -$ 2.89 (-$ 0.50) |
| Last Year's EPS | -$ 3.63 |
| EPS YoY Change |
Out of the last 77 earnings reporting periods, Tonix Pharmaceuticals Holding Corp. beat analysts’ expectations 17 times and fell short of expectations 34 time(s). Tonix Pharmaceuticals Holding Corp. reported earnings per share of -$ 2.89 in the last report falling to reach an estimated EPS of -$ 2.39 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 2.39 | -$ 2.89 | -$ 3.59 | |
| Aug 10, 2026 | -$ 2.64 | -$ 2.44 | -$ 3.86 | |
| May 11, 2026 | -$ 2.54 | -$ 2.93 | -$ 3.86 | |
| Mar 12, 2026 | -$ 3.16 | -$ 3.98 | -$ 2.84 | |
| Nov 10, 2025 | -$ 3.59 | -$ 3.59 | -$ 9.77 | |
| Aug 12, 2025 | -$ 3.10 | -$ 3.86 | -$ 23.00 | |
| Aug 11, 2025 | -$ 3.10 | -$ 3.86 | -$ 19.28 | |
| May 12, 2025 | -$ 3.23 | -$ 2.84 | -$ 1,928.00 | |
| Mar 18, 2025 | -$ 6.23 | -$ 9.77 | -$ 5.75 | |
| Nov 12, 2024 | -$ 203.00 | -$ 23.00 | -$ 2,747.60 | |
| Aug 19, 2024 | -$ 3.27 | -$ 19.28 | -$ 0.86 | |
| Aug 16, 2024 | -$ 991.00 | -$ 1,928.00 | -$ 58.47 | |
| May 13, 2024 | -$ 8.80 | -$ 5.75 | -$ 8,562.30 | |
| Apr 1, 2024 | -$ 4,984.03 | -$ 2,747.60 | -$ 10,383 | |
| Mar 25, 2024 | -$ 1.64 | -$ 0.86 | -$ 11,182 | |
| Nov 9, 2023 | -$ 47.60 | -$ 58.47 | -$ 135.68 | |
| Aug 10, 2023 | -$ 2.78 | -$ 8,562.30 | -$ 244.00 | |
| May 8, 2023 | -$ 7,987.22 | -$ 10,383 | -$ 31,898 | |
| Mar 13, 2023 | -$ 0.86 | -$ 11,182 | -$ 44,657 | |
| Nov 7, 2022 | -$ 1.02 | -$ 135.68 | -$ 31,898 |
Tonix Pharmaceuticals Holding Corp.’s stock was trading at $ 4.74 on Nov 8, 2026 a day before the last earnings report was released.Following the release of the earnings report, TNXP’s price decreased to $ 4.10 on Nov 10, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 2.89 | $ 4.74 | $ 4.10 | |
| Aug 10, 2026 | -$ 2.44 | $ 12.03 | $ 12.34 | |
| May 11, 2026 | -$ 2.93 | $ 14.09 | $ 13.28 | |
| Mar 12, 2026 | -$ 3.98 | $ 13.98 | $ 13.24 | |
| Nov 10, 2025 | -$ 3.59 | $ 17.00 | $ 17.53 | |
| Aug 12, 2025 | -$ 3.86 | $ 44.97 | $ 61.57 | |
| Aug 11, 2025 | -$ 3.86 | $ 46.49 | $ 59.76 | |
| May 12, 2025 | -$ 2.84 | $ 18.83 | $ 20.18 | |
| Mar 18, 2025 | -$ 9.77 | $ 16.28 | $ 16.47 | |
| Nov 12, 2024 | -$ 23.00 | $ 14.03 | $ 14.12 | |
| Aug 19, 2024 | -$ 19.28 | $ 44.74 | $ 38.00 | |
| Aug 16, 2024 | -$ 1,928.00 | $ 45.68 | $ 44.50 | |
| May 13, 2024 | -$ 5.75 | $ 549.44 | $ 576.00 | |
| Apr 1, 2024 | -$ 2,747.60 | $ 595.20 | $ 609.92 | |
| Mar 25, 2024 | -$ 0.86 | $ 1,107.20 | $ 1,072.00 | |
| Nov 9, 2023 | -$ 58.47 | $ 1,568.00 | $ 1,500.80 | |
| Aug 10, 2023 | -$ 8,562.30 | $ 3,040.00 | $ 3,095.68 | |
| May 8, 2023 | -$ 10,383 | $ 10,300 | $ 7,030.02 | |
| Mar 13, 2023 | -$ 11,182 | $ 12,466 | $ 13,556 | |
| Nov 7, 2022 | -$ 135.68 | $ 9,002.02 | $ 9,138.02 |
Tonix Pharmaceuticals Holding Corp. released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Tonix Pharmaceuticals Holding Corp. missed analysts’ expectations during the last earnings period by
